Henderson Jane sold APGE
January 6, 2026 · Form 4 insider transaction
Henderson Jane sold 2,000 shares of Apogee Therapeutics, Inc. at $80.00 per share, a transaction worth $160.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,000
Price
$80.00
Total value
$160.0K
InsiderHenderson Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 6, 2026
Filing dateJanuary 6, 2026
Shares owned after185,371
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.